Skip to main content
Premium Trial:

Request an Annual Quote

Saving the Trouble

Bora Zivkovic rounds up a discussion he sparked the other day after posting an article that said in the Canadian grant system, the cost of preparing a grant application (C$40,000) outweighed the amount of an average grant (C$30,000). The article then suggested to give "every qualified investigator a direct baseline discovery grant of $30,000." Zivkovic discusses where the quality control would come from -- the universities who hired the scientists in the first place and colleagues at conferences and during review for publication -- and draws from another paper on the four stages of science, and says that these baseline grants would mainly go to the first stage, the innovative stage and that would be "a Good Thing."

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.